“Global ophthalmology PCAS market will grow at a CAGR over 5% by 2030”, says Visiongain

23 January 2020

Visiongain’s new report the Ophthalmology PCAS Market Report 2020-2030: Forecasts by Type (stand alone and integrated), by Delivery Mode (cloud based and on premises) by End Use (Hospitals and Specialty Clinics) plus analysis of leading companies indicates that the global ophthalmology PCAS market will grow at a CAGR over 5% by 2030.

Increasing the use of teleophthalmology solutions due to the lack of professional ophthalmologists and optometrists are key drivers of market growth. Moreover, significant growth in Information Technology (IT) and its rising impact on the ophthalmology practices is anticipated to drive the market. In addition, high prevalence of diabetes and eye disease such as Diabetic Macular Edema (DME), diabetic retinopathy, cataract, and glaucoma are likely to boost the sector. For example, according to a report carried out by the International Diabetes Federation (IDF), some 3.27 million diabetes cases were diagnosed in France in 2017.

Increasing the burden of ophthalmic disease, high unmet medical needs in emerging economies, and increased spending on public and private health care to improve vision care services would fuel demand further. In addition, increased demand for early and reliable methods of detection is expected to fuel market growth in the coming years. Electronic Health Record (EHR) and Electronic Medical Record (EMR) programs provide healthcare service providers with complete and accurate information to help improve treatment and reducing medical errors. Government organizations will therefore take initiatives to encourage the adoption of EHR and EMR to further use ophthalmic PACS systems for fuel. The segment of Integrated Systems held the major share of the global market for PACS ophthalmology.

Such systems incorporate medical applications such as integration of data, functional integration, context integration, and integration of presentation. The diagnostic tool systems thus provide physicians with the ability to monitor medical records and test tests from anywhere and at any time. Advances in the segment's technology and service will further boost growth in the near future. Heidelberg Engineering, for example, unveiled SPECTRALIS glaucoma and retina imaging system in November 2015.

Features provided by integrated systems such as ease of understanding, good user interface, data portability, protection, cost-effectiveness and ease of deployment will provide additional fuel consumption. During the forecast period, the cloud-based system category is expected to experience the highest CAGR. Cloud-based systems provide doctors with ability to access medical records from anywhere and at any time. As a result, healthcare providers around the world are now using these devices for image delivery, monitoring, imaging research, and redundant data processing. Working with major market leaders and hospitals and clinics to offer innovative PACS technologies and services can accelerate hospital adoption. Sectra, an international medical imaging IT provider, and ProMedica, a U.S. hospital chain, signed a six-year deal to provide PACS services to ProMedica, for instance, in April 2016.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Biological Imaging Reagents Market Report 2021-2031

Increasing prevalence of cardiovascular diseases is increasing demand of biological imaging reagents for the diagnosis and treatment of cardiovascular diseases due to this reason increasing prevalence of cardiovascular diseases is acting as a driver for biological imaging reagent market.

13 November 2020


Visiongain Publishes Antihypertensive Drugs Market Report 2021-2031

Hypertensive is the most common disease around the world. However, number of people suffering from hypertensive has increased very significantly from last few years. Hypertensive can occur due to consumption of tobacco, too much salt (sodium) and little potassium in your diet, alcohol and to people being overweight or obese.

13 November 2020


Visiongain Publishes Antibacterial Drugs Market Report 2021-2031

The prevalence of bacterial diseases is significantly growing and expected to continuously rise over the forecast period. Number of bacterial diseases cases are increasing, like, bugs biting, including ticks, mosquitoes, lice and from an infected animal, contaminated food or water.

13 November 2020


Visiongain Publishes Topical Drug Delivery Market Report 2020-2030

Delivery of biologics through the transdermal route is anticipated to open new avenues for the manufacturers of topical drugs. Transdermal route provides appropriate and painless self-administration for patients. It overcomes frequent dosing administration, plasma level instability related to oral dosing and injections to uphold constant drug concentrations, and a drug with a short half-life can be supplied effortlessly.

11 November 2020